Relapse outcomes were largely null in major RCTs, including SOLAR and VIDAMS, despite numerically lower ARR in some analyses ...
Chronic kidney disease (CKD) risk stratification that flagged high-risk patients in the electronic medical record, paired ...
Columbia’s Jai Radhakrishnan, MD, MS, explains how FSGS differs by phenotype and why new IgA nephropathy drugs reach so few ...
Oncologists weighted how to choose, manage, and deliver new therapeutics beyond major academic centers. Across many disease ...
Sparsentan cut proteinuria about 70% and kept kidney function stable over 2 years in newly diagnosed IgA nephropathy in the SPARTAN study.
In 2024, Medicare Advantage insurers denied 7.7% of nearly 53 million prior authorization requests, and 80.7% of the 11.5% of denials appealed were overturned. Speakers at ASN Kidney Week urge ...
Weekly initiation of oral semaglutide among US adults eligible for obesity medications rose from nearly 0 to a peak of 4.56 ...
As CKCC nears its sunset, kidney care leaders urge CMS to preserve a dedicated, nephrologist-led accountable care model for advanced kidney disease. 259 Prospect Plains Rd, Bldg H Cranbury, NJ 08512 ...
As CKCC nears its sunset, kidney care leaders urge CMS to preserve a dedicated, nephrologist-led accountable care model for advanced kidney disease. 259 Prospect Plains Rd, Bldg H Cranbury, NJ 08512 ...
As CKCC nears its sunset, kidney care leaders urge CMS to preserve a dedicated, nephrologist-led accountable care model for advanced kidney disease. 259 Prospect Plains Rd, Bldg H Cranbury, NJ 08512 ...
As CKCC nears its sunset, kidney care leaders urge CMS to preserve a dedicated, nephrologist-led accountable care model for advanced kidney disease. 259 Prospect Plains Rd, Bldg H Cranbury, NJ 08512 ...
At IDWeek 2026, Atul Gawande, MD, MPH, said USAID cuts are costing lives but that the field is "not back at square one." Dismantling the US Agency for International Development (USAID) has cost lives ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results